Tricuspid valve disease and cardiac implantable electronic devices.
Martin AndreasHaran Burri FehraFabien PrazOsama SolimanLuigi BadanoManuel BarreiroJoão L CavalcanteTom de PotterTorsten DoenstKai FriedrichsJörg HausleiterNicole KaramSusheel KodaliAzeem LatibEloi MarijonSuneet MittalGeorg NickenigChristopher Aldo RinaldiPiotr RudzinskiMarco RussoChristoph StarckRalph Stephan von BardelebenNina WunderlichJosé Luis ZamoranoRebecca T HahnFrancesco MaisanoChristophe LeclercqPublished in: European heart journal (2023)
The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.
Keyphrases
- aortic valve
- aortic stenosis
- ejection fraction
- mitral valve
- end stage renal disease
- risk assessment
- chronic kidney disease
- newly diagnosed
- left ventricular
- machine learning
- prognostic factors
- peritoneal dialysis
- quality improvement
- heart failure
- coronary artery disease
- climate change
- patient reported outcomes
- health insurance
- fluorescence imaging
- patient reported